Holen Sie sich die Stockscreener-App
7.47
1.08%
0.08
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$7.39
Offen:
$7.33
24-Stunden-Volumen:
1.21M
Relative Volume:
0.72
Marktkapitalisierung:
$2.75B
Einnahmen:
$9.47B
Nettoeinkommen (Verlust:
$-178.00M
KGV:
-2.8295
EPS:
-2.64
Netto-Cashflow:
$1.01B
1W Leistung:
-4.35%
1M Leistung:
-8.79%
6M Leistung:
+11.00%
1J Leistung:
+3.03%
1-Tages-Spanne:
$7.33
$7.595
1-Wochen-Bereich:
$7.33
$7.83
52-Wochen-Spanne:
$3.96
$11.46
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Vergleichen Sie BHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.47 | 2.75B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Bausch + Lomb confirms potential sale is 'one of several options being explored' - MSN
Zacks Research Has Optimistic Outlook of BHC Q3 Earnings - MarketBeat
FY2024 EPS Estimates for TSE:BHC Raised by Zacks Research - MarketBeat
Zacks Research Issues Optimistic Forecast for BHC Earnings - MarketBeat
Is Bausch Health Companies (BHC) Among Billionaire Paul Singer’s Top Long-Term Stock Picks? - Yahoo Finance
Bausch Health Companies Inc. (NYSE:BHC) Stock Position Reduced by Franklin Resources Inc. - MarketBeat
Bausch Health's SWOT analysis: debt woes cloud strong q3 for diverse pharma stock - Investing.com
Canada: Bausch Health responds to rumours of potential sale of Bausch + Lomb - Investors in Healthcare
Bausch Health Companies Inc. (NYSE:BHC) Short Interest Up 9.9% in November - MarketBeat
Bausch + Lomb responds to rumors of a potential sale - The Pharma Letter
Bausch Health tanks 23.3% on unconfirmed report of bankruptcy filing - MSN
Bausch And Lomb Says Potential Sale In The Works - Law360
Contact lens maker Bausch + Lomb says it is exploring sale - Reuters
Bausch + Lomb confirms it is exploring a potential sale - Financial Post
Bausch & Lomb edges higher after confirming sales process - MSN
Bausch + Lomb Explores Potential Sale - Mergers & Acquisitions
Bausch + Lomb exploring several options including a potential sale - MSN
Bausch Health Companies Inc. - Baystreet.ca
Bausch + Lomb is exploring a potential sale - Mass Device
Bausch + Lomb responds to rumors of potential sale - Rochester Business Journal
Bausch Says Potential Sale of Bausch + Lomb Still On Table - MarketWatch
Bausch + Lomb Confirms It Is Exploring a Potential Sale - Bloomberg
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb - AccessWire
Bausch + Lomb Responds to Rumors of a Potential Sale - Business Wire
Eye health company Bausch + Lomb’s affiliate acquires Elios Vision - Yahoo! Voices
Stocks In Play: Bausch Health Companies Inc. - Barchart
Bausch Health Companies' SWOT analysis: debt woes cloud strong Q3 stock performance - Investing.com
Bausch + Lomb Shares Down on Report That Potential Buyer May Back Out - MarketWatch
Bausch + Lomb dips on rumour of failing takeover talks - pharmaphorum
XTX Topco Ltd Buys Shares of 114,898 Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Intraocular Lens Market Future Business Opportunities - openPR
Why Is Bausch Health Companies Inc. (BHC) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? - Yahoo Finance
Bausch + Lomb buyout teeters as Blackstone balks at price tag - Financial Times
Epinephrine Autoinjector Market to Grow by USD 2.44 Billion (2024-2028), Driven by Rising Allergy Prevalence and AI-Powered Market TransformationTechnavio - The Malaysian Reserve
Verition Fund Management LLC Takes $808,000 Position in Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Bausch Health : + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through One By One Recycling Program - Marketscreener.com
Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News (BLCO) - Seeking Alpha
116,591 Shares in Bausch Health Companies Inc. (NYSE:BHC) Acquired by Centiva Capital LP - MarketBeat
Readystate Asset Management LP Grows Position in Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day - Eagle-Tribune
Bausch Health Leads OIC Awareness Campaign: Tackling Critical Side Effect of Opioid Treatment - StockTitan
Medical Aesthetic Device Market is expected to grow at a CAGR - openPR
Body Contouring Devices Market: Company Profiles, Trends, - openPR
Hepatic Encephalopathy Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Salix Pharmaceuticals, Bausch Health, Axcella Health, Inc., Umecrine - The Globe and Mail
Maple Rock Capital Partners Inc. Makes New Investment in Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
Bausch Health names Jonathan Sadeh as chief medical officer - MSN
Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors - Seeking Alpha
Bausch Health Taps Jonathan Sadeh as Chief Medical Officer - MarketWatch
Bausch Health Appoints New Chief Medical Officer and Head of R&D - Batesville Daily Guard
Quantbot Technologies LP Acquires Shares of 101,543 Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):